Please use this identifier to cite or link to this item: https://doi.org/10.3389/fneur.2019.00561
DC FieldValue
dc.titleThe characteristics of patients associated with high caregiver burden in Parkinson's disease in Singapore
dc.contributor.authorTan, M.M.J.
dc.contributor.authorLim, E.C.
dc.contributor.authorNadkarni, N.V.
dc.contributor.authorLye, W.K.
dc.contributor.authorTan, E.K.
dc.contributor.authorKumar, M.P.
dc.date.accessioned2021-12-09T04:56:45Z
dc.date.available2021-12-09T04:56:45Z
dc.date.issued2019
dc.identifier.citationTan, M.M.J., Lim, E.C., Nadkarni, N.V., Lye, W.K., Tan, E.K., Kumar, M.P. (2019). The characteristics of patients associated with high caregiver burden in Parkinson's disease in Singapore. Frontiers in Neurology 10 (MAY) : 561. ScholarBank@NUS Repository. https://doi.org/10.3389/fneur.2019.00561
dc.identifier.issn1664-2295
dc.identifier.urihttps://scholarbank.nus.edu.sg/handle/10635/210044
dc.description.abstractIntroduction: Given the complex multitude of Parkinson's disease (PD) symptoms, caregiving for PD patients can be highly demanding. Our study was aimed to investigate the characteristics of PD patients related to different levels of caregiver burden. Methods: This cross-sectional study recruited 104 idiopathic PD patient-caregiver pairs. Patients were evaluated on motor, non-motor symptoms, and quality of life (QoL). Caregiver burden was quantified using Zarit Burden Inventory and subsequently stratified into 3 subgroups. Statistical analysis was performed to identify differences in the no-or little, mild-moderate, and high caregiver burden subgroups. Results: The mean disease duration was significantly longer in the high caregiver burden group compared to no-or little group (9.63 vs. 5.17 years; p-value 0.003). The mean levodopa equivalent daily dose (LEDD) and mean total UPDRS Part IV scores (UPDRS4) were significantly higher in the high caregiver burden group compared to no- or little group (p-value 0.011 and 0.004, respectively). The high caregiver burden group had significantly higher median QoL scores (PDQ-39) for PD patients for domain 2 (ADL, p-value 0.005), domain 4 (stigma, p-value 0.005), and domain 6 (cognition, p-value 0.002) compared to no-or little group. Conclusion: Greater caregiver burden was observed in PD patients with more prolonged disease duration, higher LEDD to control motor symptoms as well as greater levodopa related motor complications. Further studies on potential interventions to mitigate or delay levodopa related motor complications may reduce caregiver burden. Marked worsening in patient's QoL, specifically ADL, stigma and cognition in the high compared to no-or little caregiver burden group suggests the possible utility of monitoring these factors for early identification of increasing caregiver stress and burden. © 2019 Tan, Lim, Nadkarni, Lye, Tan and Prakash. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
dc.publisherFrontiers Media S.A.
dc.rightsAttribution 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.sourceScopus OA2019
dc.subjectCaregiver burden
dc.subjectLevodopa motor complication
dc.subjectNon-motor symptoms
dc.subjectParkinson's disease
dc.subjectQuality of life
dc.typeArticle
dc.contributor.departmentDUKE-NUS MEDICAL SCHOOL
dc.description.doi10.3389/fneur.2019.00561
dc.description.sourcetitleFrontiers in Neurology
dc.description.volume10
dc.description.issueMAY
dc.description.page561
Appears in Collections:Staff Publications
Elements

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_3389_fneur_2019_00561.pdf293.62 kBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons